Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen

CompletedOBSERVATIONAL
Enrollment

368

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

December 12, 2024

Study Completion Date

December 12, 2024

Conditions
Relapsing-remitting Multiple SclerosisActive Secondary Progressive Multiple Sclerosis
Interventions
OTHER

Kesimpta

Prospective observational cohort study. There is no treatment allocation.

Trial Locations (104)

2608677

Novartis Investigative Site, Chiba

5928555

Novartis Investigative Site, Sakai

491-0041

Novartis Investigative Site, Ichinomiya

480-1195

Novartis Investigative Site, Nagakute

453-0815

Novartis Investigative Site, Nagoya

457 8510

Novartis Investigative Site, Nagoya

467-8602

Novartis Investigative Site, Nagoya

479-0868

Novartis Investigative Site, Tokoname

441-8570

Novartis Investigative Site, Toyohashi

031-0011

Novartis Investigative Site, Hachinohe

039-1104

Novartis Investigative Site, Hachinohe

036 8563

Novartis Investigative Site, Hirosaki

272-8513

Novartis Investigative Site, Ichikawa

286-8523

Novartis Investigative Site, Narita

276-8524

Novartis Investigative Site, Yachiyo

791-0295

Novartis Investigative Site, Tōon

812-8582

Novartis Investigative Site, Fukuoka

820-8505

Novartis Investigative Site, Iizuka

802-8555

Novartis Investigative Site, Kitakyushu

830-0011

Novartis Investigative Site, Kurume

836-8566

Novartis Investigative Site, Omuta

501-1194

Novartis Investigative Site, Gifu

371 8511

Novartis Investigative Site, Maebashi

371-0847

Novartis Investigative Site, Maebashi

720-0825

Novartis Investigative Site, Fukuyama

070-8530

Novartis Investigative Site, Asahikawa

041-0821

Novartis Investigative Site, Hakodate

060 8648

Novartis Investigative Site, Sapporo

060-8543

Novartis Investigative Site, Sapporo

063-0005

Novartis Investigative Site, Sapporo

065-0021

Novartis Investigative Site, Sapporo

0730196

Novartis Investigative Site, Sunagawa

650-0047

Novartis Investigative Site, Kobe

310-0011

Novartis Investigative Site, Mito

300-0028

Novartis Investigative Site, Tsuchiura

021-0871

Novartis Investigative Site, Ichinoseki

029-0192

Novartis Investigative Site, Ichinoseki

020-8505

Novartis Investigative Site, Morioka

890 8520

Novartis Investigative Site, Kagoshima

890-8760

Novartis Investigative Site, Kagoshima

893-0023

Novartis Investigative Site, Kanoya

216-8511

Novartis Investigative Site, Kawasaki

252-0375

Novartis Investigative Site, Sagamihara

227-8501

Novartis Investigative Site, Yokohama

232 0024

Novartis Investigative Site, Yokohama

236-0004

Novartis Investigative Site, Yokohama

247-8581

Novartis Investigative Site, Yokohama

783 8505

Novartis Investigative Site, Nankoku

860-0008

Novartis Investigative Site, Kumamoto

602-8566

Novartis Investigative Site, Kyoto

616-8255

Novartis Investigative Site, Kyoto

988-0085

Novartis Investigative Site, Kesennuma

980 8574

Novartis Investigative Site, Sendai

983 8512

Novartis Investigative Site, Sendai

380-8582

Novartis Investigative Site, Nagano

381-8551

Novartis Investigative Site, Nagano

857-1195

Novartis Investigative Site, Sasebo

634 8522

Novartis Investigative Site, Kashihara

632-8552

Novartis Investigative Site, Tenri

950-1197

Novartis Investigative Site, Niigata

870-8511

Novartis Investigative Site, Ōita

710-0826

Novartis Investigative Site, Kurashiki

700-8558

Novartis Investigative Site, Okayama

583-0014

Novartis Investigative Site, Fujiidera

570-8507

Novartis Investigative Site, Moriguchi

543-8555

Novartis Investigative Site, Osaka

545-8586

Novartis Investigative Site, Osaka

556-0015

Novartis Investigative Site, Osaka

589 8511

Novartis Investigative Site, Ōsaka-sayama

565 0871

Novartis Investigative Site, Suita

350 8550

Novartis Investigative Site, Kawagoe

343-8555

Novartis Investigative Site, Koshigaya

330-8553

Novartis Investigative Site, Saitama

351-0102

Novartis Investigative Site, Wako

520-2192

Novartis Investigative Site, Ohtsu

523-0082

Novartis Investigative Site, Ōmihachiman

693 8501

Novartis Investigative Site, Izumo

431-3192

Novartis Investigative Site, Hamamatsu

323-0827

Novartis Investigative Site, Oyama

321-0293

Novartis Investigative Site, Shimotsuga Gun

329-0403

Novartis Investigative Site, Shimotsuke

113 8655

Novartis Investigative Site, Bunkyo Ku

113-8431

Novartis Investigative Site, Bunkyo Ku

134-0086

Novartis Investigative Site, Edogawa City

183-0042

Novartis Investigative Site, Fuchū

204-8585

Novartis Investigative Site, Kiyose

105-8471

Novartis Investigative Site, Minato-ku

164-8607

Novartis Investigative Site, Nakano City

160-0023

Novartis Investigative Site, Shinjuku Ku

160 8582

Novartis Investigative Site, Shinjuku-ku

930-0194

Novartis Investigative Site, Toyama

641-8510

Novartis Investigative Site, Wakayama

744-0075

Novartis Investigative Site, Kudamatsu

745-8522

Novartis Investigative Site, Shūnan

755-8505

Novartis Investigative Site, Ube

030 8553

Novartis Investigative Site, Aomori

810-0001

Novartis Investigative Site, Fukuoka

734 8530

Novartis Investigative Site, Hiroshima

650-0017

Novartis Investigative Site, Kobe

600-8558

Novartis Investigative Site, Kyoto

606 8507

Novartis Investigative Site, Kyoto

951 8520

Novartis Investigative Site, Niigata

530-8480

Novartis Investigative Site, Osaka

558-8558

Novartis Investigative Site, Osaka

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY